Semaglutide: tested on its own
288 studies: no other medicine in its arm. Page 2 of 3. Open to participants first (106), then studies with results posted, then the rest; newest registration first within each.
- Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With PrediabetesRecruitingNCT05119179Phase 4Report a problem
- Pharmacogenetics of Response to GLP1R AgonistsRecruitingNCT05071898Phase 1Report a problem
- Effect Of Semaglutide In Coronary Atheroma PlaqueNot yet recruitingNCT05071417Phase 3Report a problem
- Treatment to Regress to Normoglycemia in Women with a Recent History of GDMRecruitingNCT04873050Phase 4Report a problem
- Semaglutide's Efficacy in Achieving Weight Loss for Those With HIVRecruitingNCT04174755Not applicableReport a problem
- Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)RecruitingNCT03884075Phase 2Report a problem
- A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight RangeCompletedNCT06041217Phase 3Results postedReport a problem
- A Research Study Looking at the Effect of Semaglutide on the Immune System and Other Biological Processes in People With Alzheimer's DiseaseCompletedNCT05891496Phase 3Results postedReport a problem
- Semaglutide in CFRDCompletedNCT05788965Phase 2/3Results postedReport a problem
- Effect of GLP1 Receptor Agonists on Physical Function, Body Composition, and Markers of Aging in Older AdultsCompletedNCT05786521Phase 4Results postedReport a problem
- A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose WeightCompletedNCT05649137Phase 3Results postedReport a problem
- A Research Study to See How Semaglutide Helps People With Excess Weight, Lose Weight (STEP UP)CompletedNCT05646706Phase 3Results postedReport a problem
- A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in AmericaCompletedNCT05579249Phase 4Results postedReport a problem
- Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in People Who Have a Body Weight Above the Healthy RangeCompletedNCT05564117Phase 3Results postedReport a problem
- ADJUnct Semaglutide Treatment in Type 1 DiabetesCompletedNCT05537233Phase 2Results postedReport a problem
- Safety Study of Weekly Semaglutide in Chilean Participants With Type 2 DiabetesCompletedNCT05533632Phase 4Results postedReport a problem
- Effects of Semaglutide on Nicotine IntakeCompletedNCT05530577Phase 2Results postedReport a problem
- Semaglutide for Alcohol Use DisorderCompletedNCT05520775Phase 2Results postedReport a problem
- A Research Study to Look Into How Well Semaglutide Medicine Works at Different Doses in People With Type 2 Diabetes and OverweightCompletedNCT05486065Phase 2Results postedReport a problem
- A Research Study to Compare Two Semaglutide Medicines in People With Type 2 DiabetesCompletedNCT05478252Phase 3Results postedReport a problem
- Semaglutide Use in Elderly Obese PatientsCompletedNCT05302596Phase 2Results postedReport a problem
- Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in East Asian People Who Are Overweight or Living With ObesityCompletedNCT05132088Phase 3Results postedReport a problem
- Semaglutide 2.4 mg in Patients With Poor Weight-lossCompletedNCT05073835Phase 3Results postedReport a problem
- Research Study Looking at How Well Semaglutide Works in People Suffering From Obesity and Knee OsteoarthritisCompletedNCT05064735Phase 3Results postedReport a problem
- Research Study Looking at How Well Semaglutide Works in People Living With Obesity and PrediabetesCompletedNCT05040971Phase 3Results postedReport a problem
- Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in People Who Are Overweight or Living With Obesity (OASIS 1)CompletedNCT05035095Phase 3Results postedReport a problem
- A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE)CompletedNCT05035082Phase 4Results postedReport a problem
- Research Study Investigating How Well Semaglutide Works in People From Thailand and South Korea Living With ObesityCompletedNCT04998136Phase 3Results postedReport a problem
- Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 DiabetesCompletedNCT04916470Phase 3Results postedReport a problem
- A Research Study to Find Out How Semaglutide Works in the Kidneys Compared to Placebo, in People With Type 2 Diabetes and Chronic Kidney Disease (the REMODEL Trial)CompletedNCT04865770Phase 3Results postedReport a problem
- Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and ObesityCompletedNCT04788511Phase 3Results postedReport a problem
- GLP-1 Analogue Effects on Food Cues, Stress, Motivation for Highly Palatable Foods, and WeightCompletedNCT04779697Phase 1Results postedReport a problem
- Research Study to Compare Three Doses of Semaglutide Tablets Taken Once Daily in People With Type 2 DiabetesCompletedNCT04707469Phase 3Results postedReport a problem
- Treatment of GLP-1 for Diabetic Bariatric PatientsTerminatedNCT04624672Phase 4Results postedReport a problem
- A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 DiabetesCompletedNCT04596631Phase 3Results postedReport a problem
- A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 DiabetesCompletedNCT04560998Phase 3Results postedReport a problem
- Research Study of How Well Semaglutide Works in People Living With Overweight or Obesity.CompletedNCT04251156Phase 3Results postedReport a problem
- Study of Semaglutide for Non-Alcoholic Fatty Liver Disease (NAFLD), a Metabolic Syndrome With Insulin Resistance, Increased Hepatic Lipids, and Increased Cardiovascular Disease Risk (The SLIM LIVER Study)CompletedNCT04216589Phase 2Results postedReport a problem
- A Study Comparing the Injection Site Pain Experience After the Injection of Semaglutide B and Semaglutide D With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and ObesityCompletedNCT04143945Phase 2Results postedReport a problem
- Impact of Semaglutide on CD34+ EPC and Fat Derived MSCCompletedNCT04126603Phase 4Results postedReport a problem
- A Research Study Comparing a New Medicine Oral Semaglutide to Placebo in People With Type 2 DiabetesCompletedNCT04109547Phase 3Results postedReport a problem
- A Research Study on How Well Semaglutide Works in Adolescents With Overweight or ObesityCompletedNCT04102189Phase 3Results postedReport a problem
- Research Study to Investigate How Well Semaglutide Works Compared to Liraglutide in People Living With Overweight or ObesityCompletedNCT04074161Phase 3Results postedReport a problem
- Effects of Semaglutide in HIV-Associated LipohypertrophyCompletedNCT04019197Phase 2Results postedReport a problem
- A Research Study Comparing a New Medicine Oral Semaglutide to Sitagliptin in People With Type 2 DiabetesCompletedNCT04017832Phase 3Results postedReport a problem
- A Study Comparing the Injection Site Pain Experience After the Injection of 2 Different Solutions of Semaglutide With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and ObesityCompletedNCT04007107Phase 2Results postedReport a problem
- A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 DiabetesCompletedNCT03989232Phase 3Results postedReport a problem
- A Research Study on How Semaglutide Works in People With Fatty Liver Disease and Liver DamageCompletedNCT03987451Phase 2Results postedReport a problem
- A Heart Disease Study of Semaglutide in Patients With Type 2 DiabetesCompletedNCT03914326Phase 3Results postedReport a problem
- A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney DiseaseCompletedNCT03819153Phase 3Results postedReport a problem
- STEP 6: Research Study Investigating How Well Semaglutide Works in People Living With Overweight or ObesityCompletedNCT03811574Phase 3Results postedReport a problem
- Two-year Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or ObesityCompletedNCT03693430Phase 3Results postedReport a problem
- Research Study to Look at How Well Semaglutide is at Lowering Weight When Taken Together With an Intensive Lifestyle ProgramCompletedNCT03611582Phase 3Results postedReport a problem
- Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic TrialCompletedNCT03596450Phase 4Results postedReport a problem
- Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or ObesityCompletedNCT03574597Phase 3Results postedReport a problem
- Research Study Investigating How Well Semaglutide Works in People With Type 2 Diabetes Suffering From Overweight or ObesityCompletedNCT03552757Phase 3Results postedReport a problem
- Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or ObesityCompletedNCT03548987Phase 3Results postedReport a problem
- STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or ObesityCompletedNCT03548935Phase 3Results postedReport a problem
- Research Study Comparing a New Medicine Semaglutide to Liraglutide in People With Type 2 DiabetesCompletedNCT03191396Phase 3Results postedReport a problem
- Efficacy and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin in Subjects With Type 2 DiabetesCompletedNCT03136484Phase 3Results postedReport a problem
- Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to SGLT-2i in Subjects With Type 2 Diabetes MellitusCompletedNCT03086330Phase 3Results postedReport a problem
- Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT)CompletedNCT03061214Phase 3Results postedReport a problem
- Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With InsulinCompletedNCT03021187Phase 3Results postedReport a problem
- Dose-response, Safety and Efficacy of Oral Semaglutide Versus Placebo and Versus Liraglutide, All as Monotherapy in Japanese Subjects With Type 2 DiabetesCompletedNCT03018028Phase 3Results postedReport a problem
- Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD (Oral Antidiabetic Drug) in Japanese Subjects With Type 2 DiabetesCompletedNCT03015220Phase 3Results postedReport a problem
- Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis.CompletedNCT02970942Phase 2Results postedReport a problem
- Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Diet and Exercise OnlyCompletedNCT02906930Phase 3Results postedReport a problem
- Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes MellitusCompletedNCT02863419Phase 3Results postedReport a problem
- Efficacy and Safety of Oral Semaglutide Versus Empagliflozin in Subjects With Type 2 Diabetes MellitusCompletedNCT02863328Phase 3Results postedReport a problem
- Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitus.CompletedNCT02849080Phase 3Results postedReport a problem
- Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal ImpairmentCompletedNCT02827708Phase 3Results postedReport a problem
- A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 DiabetesCompletedNCT02692716Phase 3Results postedReport a problem
- Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.CompletedNCT02648204Phase 3Results postedReport a problem
- Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 DiabetesCompletedNCT02607865Phase 3Results postedReport a problem
- Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 DiabetesCompletedNCT02461589Phase 2Results postedReport a problem
- Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes MellitusCompletedNCT02453711Phase 2Results postedReport a problem
- Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 DiabetesCompletedNCT02305381Phase 3Results postedReport a problem
- A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly Versus Sitagliptin Once Daily in Japanese Subjects With Type 2 DiabetesCompletedNCT02254291Phase 3Results postedReport a problem
- A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly in Monotherapy or in Combination With One OAD in Japanese Subjects With Type 2 DiabetesCompletedNCT02207374Phase 3Results postedReport a problem
- Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 DiabetesCompletedNCT02128932Phase 3Results postedReport a problem
- Efficacy and Safety of Semaglutide Once-weekly Versus Placebo in Drug-naïve Subjects With Type 2 DiabetesCompletedNCT02054897Phase 3Results postedReport a problem
- Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin and/or TZD in Subjects With Type 2 DiabetesCompletedNCT01930188Phase 3Results postedReport a problem
- Multiple Dose Trial Examining Dose Range, Escalation and Efficacy of Oral Semaglutide in Subjects With Type 2 DiabetesCompletedNCT01923181Phase 2Results postedReport a problem
- Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 DiabetesCompletedNCT01885208Phase 3Results postedReport a problem
- Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 DiabetesCompletedNCT01720446Phase 3Results postedReport a problem
- Efficacy of Once Weekly Semaglutide in Patients With Type 2 Diabetes: a Non Randomized Clinical TrialCompletedNCT07732218Phase 4Report a problem
- A Research Study to See if Two Different Formulations of Oral Semaglutide Are Equally Safe and Effective in Reducing the Blood Sugar Level in Japanese People With Type 2 DiabetesCompletedNCT07271251Phase 3Report a problem
- Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS)Active, not recruitingNCT07223983Phase 1Report a problem
- Investigation of GLP1-Receptor Agonists in Men With Prostate Cancer Taking Androgen Deprivation TherapyActive, not recruitingNCT06908694Phase 4Report a problem
- A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese SubjectsCompletedNCT06738979Phase 3Report a problem
- Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIVActive, not recruitingNCT06691243Phase 2Report a problem
- Semaglutide and Intestinal Iron AbsorptionCompletedNCT06629688Not applicableReport a problem
- Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal FunctionCompletedNCT06608433Not applicableReport a problem
- STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight LossActive, not recruitingNCT06571383Phase 4Report a problem
- Effect of Oral Semaglutide on Epicardial and Pericoronary Adipose Tissues in Type 2 Diabetes After Myocardial InfarctionStatus unknownNCT06557811Phase 4Report a problem
- Open Randomized Study of Comparative Pharmacokinetics and Biosimilarity of GP40221 (GEROPHARM LLC, Russia) and Ozempic®.CompletedNCT06497049Phase 1Report a problem
- The Effects of Semaglutide vs Testosterone Replacement Therapy on Functional Hypogonadism and Sperm Quality in Men With Type 2 Diabetes Mellitus and ObesityCompletedNCT06489457Phase 3Report a problem
- Effect of Semaglutide on the Psoriatic Lesions in Patients With Type 2 Diabetes MellitusCompletedNCT06475586Phase 4Report a problem
- The Effects of Semaglutide on Body Composition and Performance in Military PersonnelWithdrawnNCT06468748Phase 4Report a problem
- The Effect of Weekly Semaglutide Treatment on Energy ExpenditureCompletedNCT06390501Not applicableReport a problem